Ralf Boscheck, B.A., CC Iowa, Econ.Philosophy, U. Marburg; M.A. Public Policy, Georgetown U.; MBA (Fin./OR/Econ.), KU Leven; PhD Economics, HSG St. Gallen; Postdoc Harvard University (Economics Department); Habilitation Law & Econ., HSG St. Gallen; Senior Consultant, Monitor Company, Cambridge, Mass. USA & London, UK.: Business Unit & Corporate Strategy & M&A; Country Competitiveness.

Since 1991, core faculty for strategy and economics in IMD’s public programs (MBA, EMBA, PED, MCR, MTE, BSPE, OWP) besides designing and facilitating in-company and strategy workshops for senior executives of corporate clients & public authorities. These include ABB, Allianz, Atkins, Aventis, Bayer*, Bayer Crop Science*, Bertelsmann, Boehringer Ingelheim*, Bonnier*, China Light & Power*, Chopard, Cisco, Clariant, Constantina*, de Mello*, Danisco*, Dupont, E.on*, Grundfos, Henkel*, Hoechst*, Holcim, Lactalis, Lundin*, Metso, Nestlé, Nestlé Health Science, Norske Shell*, Novartis Pharmaceuticals*, Novartis Emerging Markets*, Novo Nordisk*, Oracle*, Oman Electricity Authority, PwC*, Roche, Santander, Siemens*, Thames Water*, TXU Europe, Wilhelmsen*, Worley-Parsons. (*means responsibility for client acquisition or key account management). Faculty Advisor for IMD’s International Consulting Projects supporting Emerging Market NGOs.

2004-20 Lundin Family Chair of Economics & Strategy, IMD; 2014-18 Dean of IMD’s fulltime MBA program & Director of IMD’s International Consulting Projects; prior to that director of IMD’s two most senior open enrolment programs (MCR & BPSE); 2018-21 Full Professor and Decano Escuela de Negocios, Universidad Adolfo Ibañez, Santiago de Chile with continued limited teaching commitment at IMD, Lausanne. Editorial Boards.

Publications:

Books with Cambridge University Press, Palgrave Macmillan, Routledge Publishers, Difo Druck,

50+ cases & notes

50+ single-authored peer-reviewed academic journal articles

Non-refereed articles in Capital, Diario Financiero, Financial Times, Handelsblatt, Les Echos, L’Impresa, Management & Competitividad, MK-Commercio-Exterior, Neue Züricher Zeitung, Puls Bisnesu, PYMES, Der Standard, Süddeutsche Zeitung and Die Welt.

Some Examples:
2024 Reviewing State-Ownership, Bejing Law Review, Vol.15, No.2 June Issue, pp. 878-898.
2024 The EU’s Digital Market Act: Regulatory Reform, Relapse or Reversal? Intereconomics, 59(3), pp.154-9. A modified version was published as Europe’s Digital Market Act: Bold Reform or Stifling Regulation, in IbyIMD, https://www.imd.org/ibyimd/geopolitics/europes-digital-markets-act-bold-reform-or-stifling-regulation/
2021 Covid-19 and the Political Economy of Shared Adjustment, Intereconomics, Vol. 56, No.5,
September/October 2021, pp.278-283. A modified version was published as Economía política y ajuste conjunto en perspectiva europea, in Osorio, H., Soto G.Y. (eds.) Negocios en América Latina después del COVID-19, Rubicona;
2017 Pharmacy Benefit Managers: Fixing Healthcare Market Failures or Straining Regulatory
Logics? World Competition: Law & Economics Review, Vol.40, No.3, pp. 459-470.
Syntheses entitled Pharmacy Benefit Managers: Fixing Healthcare Market Failures or Straining Regulatory Control and Enforcement and Regulatory Responses to the Pharmacy Benefit Manager Debate were reproduced a.o. by biosimilardevelopment.com;
2016 Patent Trolls: In Search of Efficient Regulatory Standards, World Competition: Law & Economics Review, Vol. 39, No. 1, pp. 67-84. A synthesis entitled Keeping an eye on patent trolls was reproduced a.o. by IPWatchdog.com; IPCircuit.com and Global IP News.com;
2015 Intellectual Property Rights and the Evergreening of Pharmaceuticals, Intereconomics, Vol. 50, No.4, July/August 2015, pp. 221-226.